Loss of PTEN Expression Is an Independent Predictor of Recurrence in Prostate Adenocarcinoma

被引：0
|
作者：
Schultz, L. [1 ]
Platz, E. [1 ]
Hicks, J. [1 ]
Toubaji, A. [1 ]
Isaacs, W. B. [1 ]
Meeker, A. [1 ]
Demarzo, A. M. [1 ]
Netto, G. J. [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
来源：
LABORATORY INVESTIGATION | 2010年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
973
引用
收藏
页码：218A / 218A
页数：1
相关论文
共 50 条
  • [31] Prostate cancer: Loss of PTEN promotes progression of prostate cancer in an androgen-independent manner
    Warde N.
    Nature Reviews Urology, 2011, 8 (8) : 412 - 412
  • [32] Loss of PTEN Expression in Pancreatic Ductal Adenocarcinoma Is Associated with Poor Survival
    Foo, W.
    Rashid, A.
    Wang, H.
    Hamilton, S.
    Katz, M. H.
    Lee, J. E.
    Gomez, H. F.
    Abbruzzese, J. L.
    Fleming, J. B.
    Wang, H.
    LABORATORY INVESTIGATION, 2012, 92 : 442A - 443A
  • [33] Loss of PTEN Expression Is Associated with Poor Prognosis in Patients with Ampullary Adenocarcinoma
    Shroff, S.
    Overman, M.
    Rashid, A.
    Wang, H.
    Shroff, R.
    Hamilton, S.
    Katz, M. H.
    Lee, J. E.
    Gomez, H. F.
    Abbruzzese, J. L.
    Fleming, J. B.
    Wang, H.
    LABORATORY INVESTIGATION, 2012, 92 : 448A - 448A
  • [34] Loss of PTEN Expression Is Associated with Poor Prognosis in Patients with Ampullary Adenocarcinoma
    Shroff, S.
    Overman, M.
    Rashid, A.
    Wang, H.
    Shroff, R.
    Hamilton, S.
    Katz, M. H.
    Lee, J. E.
    Gomez, H. F.
    Abbruzzese, J. L.
    Fleming, J. B.
    Wang, H.
    MODERN PATHOLOGY, 2012, 25 : 448A - 448A
  • [35] Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms:: is PTEN loss predictor of local recurrence?
    Colakoglu, Tamer
    Yildirim, Sedat
    Kayaselcuk, Fazilet
    Nursal, Tarik Zafer
    Ezer, Ali
    Noyan, Turgut
    Karakayali, Hamdi
    Haberal, Mehmet
    AMERICAN JOURNAL OF SURGERY, 2008, 195 (06): : 719 - 725
  • [36] Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers
    Andreas M.Luebke
    Ali Attarchi-Tehrani
    Jan Meiners
    Claudia Hube-Magg
    Dagmar S.Lang
    Martina Kluth
    Maria Christina Tsourlakis
    Sarah Minner
    Ronald Simon
    Guido Sauter
    Franziska Büscheck
    Frank Jacobsen
    Andrea Hinsch
    Stefan Steurer
    Thorsten Schlomm
    Hartwig Huland
    Markus Graefen
    Alexander Haese
    Hans Heinzer
    Till S.Clauditz
    Eike Burandt
    Waldemar Wilczak
    Doris H?flmayer
    Cancer Biology & Medicine, 2019, (02) : 319 - 330
  • [37] Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers
    Andreas MLuebke
    Ali AttarchiTehrani
    Jan Meiners
    Claudia HubeMagg
    Dagmar SLang
    Martina Kluth
    Maria Christina Tsourlakis
    Sarah Minner
    Ronald Simon
    Guido Sauter
    Franziska Bscheck
    Frank Jacobsen
    Andrea Hinsch
    Stefan Steurer
    Thorsten Schlomm
    Hartwig Huland
    Markus Graefen
    Alexander Haese
    Hans Heinzer
    Till SClauditz
    Eike Burandt
    Waldemar Wilczak
    Doris Hflmayer
    Cancer Biology & Medicine, 2019, 16 (02) : 319 - 330
  • [38] Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers
    Luebke, Andreas M.
    Attarchi-Tehrani, Ali
    Meiners, Jan
    Hube-Magg, Claudia
    Lang, Dagmar S.
    Kluth, Martina
    Tsourlakis, Maria Christina
    Minner, Sarah
    Simon, Ronald
    Sauter, Guido
    Buescheck, Franziska
    Jacobsen, Frank
    Hinsch, Andrea
    Steurer, Stefan
    Schlomm, Thorsten
    Huland, Hartwig
    Graefen, Markus
    Haese, Alexander
    Heinzer, Hans
    Clauditz, Till S.
    Burandt, Eike
    Wilczak, Waldemar
    Hoeflmayer, Doris
    CANCER BIOLOGY & MEDICINE, 2019, 16 (02) : 319 - 330
  • [39] Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers
    Burdelski, Christoph
    Bujupi, Erzen
    Tsourlakis, Maria Christina
    Hube-Magg, Claudia
    Kluth, Martina
    Melling, Nathaniel
    Lebok, Patrick
    Minner, Sarah
    Koop, Christina
    Graefen, Markus
    Heinzer, Hans
    Wittmer, Corinna
    Sauter, Guido
    Wilczak, Waldemar
    Simon, Ronald
    Schlomm, Thorsten
    Steurer, Stefan
    Krech, Till
    PLOS ONE, 2015, 10 (06):
  • [40] PTEN loss contributes to prostate carcinogenesis through Akt-independent mechanisms
    Inokuchi, Junichi
    Wulfkuhle, Julia
    Petricoin, Emanuel
    Ornstein, David
    Tyson, Darren
    CANCER RESEARCH, 2009, 69
12345